MICROBOT MEDICAL INC. - COMMON STOCK

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

20 Aug 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

05 Aug 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

22 Jul 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

08 Jul 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® Added to the Russell Microcap® Index

30 Jun 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

17 Jun 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

09 Jun 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

05 Jun 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

23 Apr 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

09 Apr 2025 05:30:00 By Nasdaq GlobeNewswire

REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

01 Apr 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

04 Mar 2025 05:30:00 By Nasdaq GlobeNewswire

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

25 Feb 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Closes $13 Million Registered Direct Offering

11 Feb 2025 15:15:48 By Nasdaq GlobeNewswire

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

10 Feb 2025 05:00:00 By Nasdaq GlobeNewswire

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

04 Feb 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®

21 Jan 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors

13 Jan 2025 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Closes $8.6 Million Registered Direct Offering

10 Jan 2025 07:25:51 By Nasdaq GlobeNewswire

Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

08 Jan 2025 05:00:00 By Nasdaq GlobeNewswire